查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1874397

药品追踪与管理解决方案：全球市占率与排名、总收入及需求预测（2025-2031年）

Pharma Track and Trace Solutions - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 118 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球药品追踪和管理解决方案市场预计在 2024 年达到 22.23 亿美元，预计到 2031 年将达到 60.13 亿美元，在预测期（2025-2031 年）内以 15.5% 的复合年增长率增长。

可追溯性解决方案不仅仅是提高供应链效率的经济方案。专家估计，全球销售的药品有5%是仿冒品，在某些国家，这一比例甚至高达50%。每年有数十亿件产品「在供应链中丢失」。假药和非法分销不仅危及生命，还会造成收入损失，并损害企业声誉。製药业必须确保其供应链安全，并具备验证产品电子谱系（ePedigree）或生命週期的能力。可追溯性解决方案是这项策略的重要组成部分。它们可以识别药品的来源并检验其真伪。此外，可追溯性解决方案还有助于打击产品转移，即合法产品在不同市场之间未经授权的流动，这会影响授权义务、分销协议和收入。

药品追踪解决方案市场的主要驱动力是人们对全球药品供应链安全和病患安全日益增长的担忧。市场上假药的氾滥促使世界各地的监管机构实施严格的序列化和可追溯性要求，例如美国的《药品供应链安全法案》(DSCSA)、欧盟的《假药指令》(FMD) 以及其他地区的类似法规。这些监管要求迫使製药公司采用先进的追踪溯源技术，以符合法律标准并避免处罚。此外，全球药品供应链日益复杂，涉及多个地域的相关人员，因此，能够提供端到端可视性和透明度的强大解决方案至关重要。区块链、无线射频识别 (RFID) 和物联网 (IoT) 等创新技术的应用将透过增强即时监控能力和确保资料完整性，进一步推动市场成长。此外，消费者和医疗保健提供者对药品真实性和安全性的日益关注，也催生了对可靠追踪系统的需求。製药企业和技术供应商在开发经济高效、扩充性且可互通的追踪溯源解决方案方面的投资，也大大促进了市场扩张。

儘管药品追踪解决方案市场前景广阔，但仍面临许多挑战，可能阻碍其发展。其中一个主要障碍是先进追踪技术的高昂实施成本。对于中小型製药公司，尤其是新兴市场的企业而言，基础设施升级、员工培训以及与现有企业系统的整合都需要大量资金和时间，这可能会延缓技术的采用。此外，缺乏标准化的全球法规以及各国合规要求的差异，造成了市场的复杂性和碎片化，使得製造商难以在全球范围内实施统一的解决方案。不同追踪系统之间的互通性问题以及资料隐私问题也构成重大障碍。此外，造假者和供应链犯罪分子不断演变的策略，也要求追踪解决方案持续创新和更新，加剧了营运挑战。传统供应链网络内部对变革的抵制以及不同相关人员之间协作的需求，进一步增加了实施难度。应对这些挑战对于充分发挥药品追踪系统在保障药品供应链安全和病人安全的潜力至关重要。

本报告旨在按地区/国家、类型和应用对全球药品追踪解决方案市场进行全面分析，重点关注总收入、市场份额和主要企业的排名。

本报告以销售收入为指标，对药品追踪溯源解决方案的市场规模、估算和预测进行了呈现，以2024年为基准年，并涵盖了2020年至2031年的历史数据和预测数据。报告采用定量和定性分析相结合的方法，帮助读者制定业务和成长策略，评估市场竞争，分析自身在当前市场中的地位，并就药品追踪溯源解决方案做出明智的商业决策。

市场区隔

公司

  • Optel Vision
  • Siemens
  • IBM
  • Axway
  • Mettler-Toledo
  • Systech
  • SAP
  • Seidenader Maschinenbau
  • Antares Vision
  • Sea Vision
  • TraceLink
  • Adents International
  • Xyntek
  • Holoflex
  • ACG Worldwide

按类型分類的细分市场

  • 条码
  • RFID

应用领域

  • 生物製药
  • 化学和製药
  • 专科药物

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Pharma Track and Trace Solutions was estimated to be worth US$ 2223 million in 2024 and is forecast to a readjusted size of US$ 6013 million by 2031 with a CAGR of 15.5% during the forecast period 2025-2031.

Track and trace solutions are not just economic measures for supply-chain efficiency. Experts estimate that 5% of all drugs sold worldwide are counterfeits - in some countries, figures even reach a shocking 50 %. Billions of products are "lost in the supply chain" every year. Counterfeit drugs and product diversion risk lives, undermine revenues, and threaten company reputations. The pharmaceutical industry needs to ensure supply-chain security and gain the ability to authenticate the ePedigree, or life history, of a product. Track and trace solutions are an essential part of this strategy. Track and trace solutions identify the origins of a pharmaceutical industry product and verify its authenticity. Moreover, track and trace solutions also help combat product diversion, whereby legitimate products are diverted from one market to another, with implications for licensing obligations and distribution agreements as well as for revenues.

The Pharma Track and Trace Solutions market is primarily driven by the growing global emphasis on pharmaceutical supply chain security and patient safety. Increasing incidences of counterfeit drugs flooding the market have pushed regulatory authorities worldwide to implement stringent serialization and traceability mandates, such as the U.S. Drug Supply Chain Security Act (DSCSA), the European Union Falsified Medicines Directive (FMD), and similar regulations in other regions. These regulatory requirements compel pharmaceutical companies to adopt advanced track and trace technologies to comply with legal standards and avoid penalties. Additionally, the rising complexity of global pharmaceutical supply chains, involving multiple stakeholders across geographies, necessitates robust solutions that provide end-to-end visibility and transparency. The adoption of innovative technologies like blockchain, RFID, and Internet of Things (IoT) further accelerates market growth by enhancing real-time monitoring capabilities and ensuring data integrity. Moreover, the increasing awareness among consumers and healthcare providers about drug authenticity and safety is creating demand for reliable tracking systems. Investments by pharmaceutical manufacturers and technology providers in developing cost-effective, scalable, and interoperable track and trace solutions also contribute significantly to market expansion.

Despite the promising growth prospects, the Pharma Track and Trace Solutions market faces several challenges that could impede its progress. One of the main hurdles is the high implementation cost associated with advanced track and trace technologies, especially for small and mid-sized pharmaceutical companies operating in emerging markets. The need for infrastructure upgrades, staff training, and integration with existing enterprise systems requires substantial capital and time investments, which may delay adoption. Furthermore, the lack of standardized global regulations and varying compliance requirements across countries create complexity and fragmentation, making it difficult for manufacturers to implement uniform solutions worldwide. Interoperability issues between different track and trace systems and data privacy concerns also pose significant barriers. Additionally, the constantly evolving tactics of counterfeiters and supply chain criminals require continuous innovation and updates to tracking solutions, increasing operational challenges. Resistance to change within traditional supply chain networks and the requirement for collaboration among diverse stakeholders further complicate deployment efforts. Addressing these challenges is critical for realizing the full potential of pharma track and trace systems in safeguarding the pharmaceutical supply chain and ensuring patient safety.

This report aims to provide a comprehensive presentation of the global market for Pharma Track and Trace Solutions, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pharma Track and Trace Solutions by region & country, by Type, and by Application.

The Pharma Track and Trace Solutions market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma Track and Trace Solutions.

Market Segmentation

By Company

  • Optel Vision
  • Siemens
  • IBM
  • Axway
  • Mettler-Toledo
  • Systech
  • SAP
  • Seidenader Maschinenbau
  • Antares Vision
  • Sea Vision
  • TraceLink
  • Adents International
  • Xyntek
  • Holoflex
  • ACG Worldwide

Segment by Type

  • Barcodes
  • RFID

Segment by Application

  • Bio Pharma
  • Chemical Pharma
  • Specially Pharma

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Pharma Track and Trace Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Pharma Track and Trace Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Pharma Track and Trace Solutions in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Pharma Track and Trace Solutions Product Introduction
  • 1.2 Global Pharma Track and Trace Solutions Market Size Forecast (2020-2031)
  • 1.3 Pharma Track and Trace Solutions Market Trends & Drivers
    • 1.3.1 Pharma Track and Trace Solutions Industry Trends
    • 1.3.2 Pharma Track and Trace Solutions Market Drivers & Opportunity
    • 1.3.3 Pharma Track and Trace Solutions Market Challenges
    • 1.3.4 Pharma Track and Trace Solutions Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Pharma Track and Trace Solutions Players Revenue Ranking (2024)
  • 2.2 Global Pharma Track and Trace Solutions Revenue by Company (2020-2025)
  • 2.3 Key Companies Pharma Track and Trace Solutions Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Pharma Track and Trace Solutions Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Pharma Track and Trace Solutions
  • 2.6 Pharma Track and Trace Solutions Market Competitive Analysis
    • 2.6.1 Pharma Track and Trace Solutions Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Pharma Track and Trace Solutions Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Track and Trace Solutions as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Barcodes
    • 3.1.2 RFID
  • 3.2 Global Pharma Track and Trace Solutions Sales Value by Type
    • 3.2.1 Global Pharma Track and Trace Solutions Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Pharma Track and Trace Solutions Sales Value, by Type (2020-2031)
    • 3.2.3 Global Pharma Track and Trace Solutions Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Bio Pharma
    • 4.1.2 Chemical Pharma
    • 4.1.3 Specially Pharma
  • 4.2 Global Pharma Track and Trace Solutions Sales Value by Application
    • 4.2.1 Global Pharma Track and Trace Solutions Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Pharma Track and Trace Solutions Sales Value, by Application (2020-2031)
    • 4.2.3 Global Pharma Track and Trace Solutions Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Pharma Track and Trace Solutions Sales Value by Region
    • 5.1.1 Global Pharma Track and Trace Solutions Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Pharma Track and Trace Solutions Sales Value by Region (2020-2025)
    • 5.1.3 Global Pharma Track and Trace Solutions Sales Value by Region (2026-2031)
    • 5.1.4 Global Pharma Track and Trace Solutions Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 5.2.2 North America Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 5.3.2 Europe Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Pharma Track and Trace Solutions Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 5.5.2 South America Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Pharma Track and Trace Solutions Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Pharma Track and Trace Solutions Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 6.3.2 United States Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 6.4.2 Europe Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 6.5.2 China Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 6.6.2 Japan Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 6.7.2 South Korea Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 6.9.2 India Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Optel Vision
    • 7.1.1 Optel Vision Profile
    • 7.1.2 Optel Vision Main Business
    • 7.1.3 Optel Vision Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.1.4 Optel Vision Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Optel Vision Recent Developments
  • 7.2 Siemens
    • 7.2.1 Siemens Profile
    • 7.2.2 Siemens Main Business
    • 7.2.3 Siemens Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.2.4 Siemens Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Siemens Recent Developments
  • 7.3 IBM
    • 7.3.1 IBM Profile
    • 7.3.2 IBM Main Business
    • 7.3.3 IBM Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.3.4 IBM Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.3.5 IBM Recent Developments
  • 7.4 Axway
    • 7.4.1 Axway Profile
    • 7.4.2 Axway Main Business
    • 7.4.3 Axway Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.4.4 Axway Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Axway Recent Developments
  • 7.5 Mettler-Toledo
    • 7.5.1 Mettler-Toledo Profile
    • 7.5.2 Mettler-Toledo Main Business
    • 7.5.3 Mettler-Toledo Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.5.4 Mettler-Toledo Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Mettler-Toledo Recent Developments
  • 7.6 Systech
    • 7.6.1 Systech Profile
    • 7.6.2 Systech Main Business
    • 7.6.3 Systech Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.6.4 Systech Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Systech Recent Developments
  • 7.7 SAP
    • 7.7.1 SAP Profile
    • 7.7.2 SAP Main Business
    • 7.7.3 SAP Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.7.4 SAP Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.7.5 SAP Recent Developments
  • 7.8 Seidenader Maschinenbau
    • 7.8.1 Seidenader Maschinenbau Profile
    • 7.8.2 Seidenader Maschinenbau Main Business
    • 7.8.3 Seidenader Maschinenbau Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.8.4 Seidenader Maschinenbau Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Seidenader Maschinenbau Recent Developments
  • 7.9 Antares Vision
    • 7.9.1 Antares Vision Profile
    • 7.9.2 Antares Vision Main Business
    • 7.9.3 Antares Vision Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.9.4 Antares Vision Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Antares Vision Recent Developments
  • 7.10 Sea Vision
    • 7.10.1 Sea Vision Profile
    • 7.10.2 Sea Vision Main Business
    • 7.10.3 Sea Vision Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.10.4 Sea Vision Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Sea Vision Recent Developments
  • 7.11 TraceLink
    • 7.11.1 TraceLink Profile
    • 7.11.2 TraceLink Main Business
    • 7.11.3 TraceLink Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.11.4 TraceLink Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.11.5 TraceLink Recent Developments
  • 7.12 Adents International
    • 7.12.1 Adents International Profile
    • 7.12.2 Adents International Main Business
    • 7.12.3 Adents International Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.12.4 Adents International Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Adents International Recent Developments
  • 7.13 Xyntek
    • 7.13.1 Xyntek Profile
    • 7.13.2 Xyntek Main Business
    • 7.13.3 Xyntek Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.13.4 Xyntek Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.13.5 Xyntek Recent Developments
  • 7.14 Holoflex
    • 7.14.1 Holoflex Profile
    • 7.14.2 Holoflex Main Business
    • 7.14.3 Holoflex Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.14.4 Holoflex Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.14.5 Holoflex Recent Developments
  • 7.15 ACG Worldwide
    • 7.15.1 ACG Worldwide Profile
    • 7.15.2 ACG Worldwide Main Business
    • 7.15.3 ACG Worldwide Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.15.4 ACG Worldwide Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.15.5 ACG Worldwide Recent Developments

8 Industry Chain Analysis

  • 8.1 Pharma Track and Trace Solutions Industrial Chain
  • 8.2 Pharma Track and Trace Solutions Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Pharma Track and Trace Solutions Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Pharma Track and Trace Solutions Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Pharma Track and Trace Solutions Market Trends
  • Table 2. Pharma Track and Trace Solutions Market Drivers & Opportunity
  • Table 3. Pharma Track and Trace Solutions Market Challenges
  • Table 4. Pharma Track and Trace Solutions Market Restraints
  • Table 5. Global Pharma Track and Trace Solutions Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Pharma Track and Trace Solutions Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Pharma Track and Trace Solutions Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Pharma Track and Trace Solutions Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Pharma Track and Trace Solutions
  • Table 10. Global Pharma Track and Trace Solutions Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Track and Trace Solutions as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Pharma Track and Trace Solutions Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Pharma Track and Trace Solutions Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Pharma Track and Trace Solutions Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Pharma Track and Trace Solutions Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Pharma Track and Trace Solutions Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Pharma Track and Trace Solutions Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Pharma Track and Trace Solutions Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Pharma Track and Trace Solutions Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Pharma Track and Trace Solutions Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Pharma Track and Trace Solutions Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Pharma Track and Trace Solutions Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Pharma Track and Trace Solutions Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Pharma Track and Trace Solutions Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Pharma Track and Trace Solutions Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Pharma Track and Trace Solutions Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Pharma Track and Trace Solutions Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Pharma Track and Trace Solutions Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Pharma Track and Trace Solutions Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Optel Vision Basic Information List
  • Table 32. Optel Vision Description and Business Overview
  • Table 33. Optel Vision Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of Optel Vision (2020-2025)
  • Table 35. Optel Vision Recent Developments
  • Table 36. Siemens Basic Information List
  • Table 37. Siemens Description and Business Overview
  • Table 38. Siemens Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of Siemens (2020-2025)
  • Table 40. Siemens Recent Developments
  • Table 41. IBM Basic Information List
  • Table 42. IBM Description and Business Overview
  • Table 43. IBM Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of IBM (2020-2025)
  • Table 45. IBM Recent Developments
  • Table 46. Axway Basic Information List
  • Table 47. Axway Description and Business Overview
  • Table 48. Axway Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of Axway (2020-2025)
  • Table 50. Axway Recent Developments
  • Table 51. Mettler-Toledo Basic Information List
  • Table 52. Mettler-Toledo Description and Business Overview
  • Table 53. Mettler-Toledo Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of Mettler-Toledo (2020-2025)
  • Table 55. Mettler-Toledo Recent Developments
  • Table 56. Systech Basic Information List
  • Table 57. Systech Description and Business Overview
  • Table 58. Systech Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of Systech (2020-2025)
  • Table 60. Systech Recent Developments
  • Table 61. SAP Basic Information List
  • Table 62. SAP Description and Business Overview
  • Table 63. SAP Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of SAP (2020-2025)
  • Table 65. SAP Recent Developments
  • Table 66. Seidenader Maschinenbau Basic Information List
  • Table 67. Seidenader Maschinenbau Description and Business Overview
  • Table 68. Seidenader Maschinenbau Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of Seidenader Maschinenbau (2020-2025)
  • Table 70. Seidenader Maschinenbau Recent Developments
  • Table 71. Antares Vision Basic Information List
  • Table 72. Antares Vision Description and Business Overview
  • Table 73. Antares Vision Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of Antares Vision (2020-2025)
  • Table 75. Antares Vision Recent Developments
  • Table 76. Sea Vision Basic Information List
  • Table 77. Sea Vision Description and Business Overview
  • Table 78. Sea Vision Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of Sea Vision (2020-2025)
  • Table 80. Sea Vision Recent Developments
  • Table 81. TraceLink Basic Information List
  • Table 82. TraceLink Description and Business Overview
  • Table 83. TraceLink Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of TraceLink (2020-2025)
  • Table 85. TraceLink Recent Developments
  • Table 86. Adents International Basic Information List
  • Table 87. Adents International Description and Business Overview
  • Table 88. Adents International Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of Adents International (2020-2025)
  • Table 90. Adents International Recent Developments
  • Table 91. Xyntek Basic Information List
  • Table 92. Xyntek Description and Business Overview
  • Table 93. Xyntek Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of Xyntek (2020-2025)
  • Table 95. Xyntek Recent Developments
  • Table 96. Holoflex Basic Information List
  • Table 97. Holoflex Description and Business Overview
  • Table 98. Holoflex Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 99. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of Holoflex (2020-2025)
  • Table 100. Holoflex Recent Developments
  • Table 101. ACG Worldwide Basic Information List
  • Table 102. ACG Worldwide Description and Business Overview
  • Table 103. ACG Worldwide Pharma Track and Trace Solutions Products, Services and Solutions
  • Table 104. Revenue (US$ Million) in Pharma Track and Trace Solutions Business of ACG Worldwide (2020-2025)
  • Table 105. ACG Worldwide Recent Developments
  • Table 106. Key Raw Materials Lists
  • Table 107. Raw Materials Key Suppliers Lists
  • Table 108. Pharma Track and Trace Solutions Downstream Customers
  • Table 109. Pharma Track and Trace Solutions Distributors List
  • Table 110. Research Programs/Design for This Report
  • Table 111. Key Data Information from Secondary Sources
  • Table 112. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Pharma Track and Trace Solutions Product Picture
  • Figure 2. Global Pharma Track and Trace Solutions Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Pharma Track and Trace Solutions Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Pharma Track and Trace Solutions Report Years Considered
  • Figure 5. Global Pharma Track and Trace Solutions Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Pharma Track and Trace Solutions Revenue in 2024
  • Figure 7. Pharma Track and Trace Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Barcodes Picture
  • Figure 9. RFID Picture
  • Figure 10. Global Pharma Track and Trace Solutions Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 11. Global Pharma Track and Trace Solutions Sales Value Market Share by Type, 2024 & 2031
  • Figure 12. Product Picture of Bio Pharma
  • Figure 13. Product Picture of Chemical Pharma
  • Figure 14. Product Picture of Specially Pharma
  • Figure 15. Global Pharma Track and Trace Solutions Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 16. Global Pharma Track and Trace Solutions Sales Value Market Share by Application, 2024 & 2031
  • Figure 17. North America Pharma Track and Trace Solutions Sales Value (2020-2031) & (US$ Million)
  • Figure 18. North America Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031
  • Figure 19. Europe Pharma Track and Trace Solutions Sales Value, (2020-2031) & (US$ Million)
  • Figure 20. Europe Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031
  • Figure 21. Asia Pacific Pharma Track and Trace Solutions Sales Value, (2020-2031) & (US$ Million)
  • Figure 22. Asia Pacific Pharma Track and Trace Solutions Sales Value by Region (%), 2024 VS 2031
  • Figure 23. South America Pharma Track and Trace Solutions Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. South America Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031
  • Figure 25. Middle East & Africa Pharma Track and Trace Solutions Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. Middle East & Africa Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Key Countries/Regions Pharma Track and Trace Solutions Sales Value (%), (2020-2031)
  • Figure 28. United States Pharma Track and Trace Solutions Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. United States Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
  • Figure 30. United States Pharma Track and Trace Solutions Sales Value by Application (%), 2024 VS 2031
  • Figure 31. Europe Pharma Track and Trace Solutions Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Europe Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
  • Figure 33. Europe Pharma Track and Trace Solutions Sales Value by Application (%), 2024 VS 2031
  • Figure 34. China Pharma Track and Trace Solutions Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. China Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
  • Figure 36. China Pharma Track and Trace Solutions Sales Value by Application (%), 2024 VS 2031
  • Figure 37. Japan Pharma Track and Trace Solutions Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. Japan Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
  • Figure 39. Japan Pharma Track and Trace Solutions Sales Value by Application (%), 2024 VS 2031
  • Figure 40. South Korea Pharma Track and Trace Solutions Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. South Korea Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
  • Figure 42. South Korea Pharma Track and Trace Solutions Sales Value by Application (%), 2024 VS 2031
  • Figure 43. Southeast Asia Pharma Track and Trace Solutions Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. Southeast Asia Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
  • Figure 45. Southeast Asia Pharma Track and Trace Solutions Sales Value by Application (%), 2024 VS 2031
  • Figure 46. India Pharma Track and Trace Solutions Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. India Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
  • Figure 48. India Pharma Track and Trace Solutions Sales Value by Application (%), 2024 VS 2031
  • Figure 49. Pharma Track and Trace Solutions Industrial Chain
  • Figure 50. Pharma Track and Trace Solutions Manufacturing Cost Structure
  • Figure 51. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 52. Bottom-up and Top-down Approaches for This Report
  • Figure 53. Data Triangulation
  • Figure 54. Key Executives Interviewed